Argen X (Belgium) Today
| ARGX Stock | EUR 582.40 5.80 1.01% |
Performance14 of 100
| Odds Of DistressLess than 34
|
Argen X is selling at 582.40 as of the 28th of November 2024; that is 1.01% up since the beginning of the trading day. The stock's lowest day price was 577.0. Argen X has about a 34 percent probability of financial distress in the next few years of operation but had a somewhat good performance during the last 90 days. Equity ratings for Argen X are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 29th of October 2024 and ending today, the 28th of November 2024. Click here to learn more.
argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Ltd, Universit Catholique de Louvain, Sopartec S.A., NYU Langone Health, Leiden University Medical Center, AgomAb Therapeutics NV, Broteio Pharma B.V., University of Texas, BioWa, Inc., Cilag GmbH International, Staten Biotechnology B.V., and Shire International GmbH. The company has 55.47 M outstanding shares. More on Argen X
Moving together with Argen Stock
Moving against Argen Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Argen Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Argen X's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Argen X or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) |
Argen X (ARGX) is traded on Euronext Brussels in Belgium and employs 650 people. The company currently falls under 'Large-Cap' category with a current market capitalization of 19.43 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Argen X's market, we take the total number of its shares issued and multiply it by Argen X's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Argen X operates under Biotechnology sector and is part of Health Care industry. The entity has 55.47 M outstanding shares.
Argen X has accumulated about 2.6 B in cash with (606.81 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 47.17.
Check Argen X Probability Of Bankruptcy
Ownership AllocationArgen X holds a total of 55.47 Million outstanding shares. 30% of Argen X outstanding shares are owned by other corporate entities. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Argen Ownership Details
Argen X Risk Profiles
Although Argen X's alpha and beta are two of the key measurements used to evaluate Argen X's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.29 | |||
| Semi Deviation | 1.47 | |||
| Standard Deviation | 1.77 | |||
| Variance | 3.12 |
Argen Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Argen X without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Positions Ratings Now
Positions RatingsDetermine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |
| All Next | Launch Module |
Argen X Corporate Management
Elected by the shareholders, the Argen X's board of directors comprises two types of representatives: Argen X inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Argen. The board's role is to monitor Argen X's management team and ensure that shareholders' interests are well served. Argen X's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Argen X's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Karl Gubitz | Chief Officer | Profile | |
| Beth DelGiacco | VP Relations | Profile | |
| Malini Moorthy | G Counsel | Profile | |
| EMBA MBA | CEO Director | Profile | |
| Filip Borgions | VP Operations | Profile | |
| Pr Ir | CoFounder Officer | Profile | |
| Keith Woods | Chief Officer | Profile |
Additional Tools for Argen Stock Analysis
When running Argen X's price analysis, check to measure Argen X's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Argen X is operating at the current time. Most of Argen X's value examination focuses on studying past and present price action to predict the probability of Argen X's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Argen X's price. Additionally, you may evaluate how the addition of Argen X to your portfolios can decrease your overall portfolio volatility.